4processed

Form 4 — Insider Transaction

KalVista Pharmaceuticals, Inc.(KALV)

Filing Date

June 11, 2026

Accepted

June 11, 2026

Accession No.

0001899935-26-000007

CIK

0001348911

Insider Transactions

InsiderTitleTypeSharesPriceValueOwned AfterSecurityDate
Sensenig BethanyOther45.0K0Stock Option (Right to Buy)Jun 11, 2026